Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children
about
Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infectionIgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United StatesDual Recognition Element Lateral Flow Assay Toward Multiplex Strain Specific Influenza Virus Detection.Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals.Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies.Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza.Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza.Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary InfectionCross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A virusesProtection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains.Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypesB cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms.Human antibody responses to avian influenza A(H7N9) virus, 2013.Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.Antibody quantity versus quality after influenza vaccination.
P2860
Q30328172-A35F5B09-3494-4252-81A1-2305E2B7CD3AQ30362980-4D01700E-8263-4090-879A-6E6608816E02Q30402541-50248E49-6509-4849-8120-09098178484FQ33809686-388EFDA0-2FAE-4A3B-A42A-77D536470E4CQ33974507-A8871E8F-95B1-4453-AEC5-F6F0A6EDAE7FQ34756837-02DD1B1D-CB2E-4743-9D7D-8CC2B7186478Q35671981-527FD1F9-027D-4A11-9ADD-E497A9CAF0C2Q36251479-7272BFB9-0433-466D-A3E3-BE74D9792D2FQ36365301-1A753062-56FD-47D4-81A7-C7D649E4252EQ36611283-401BB374-81AB-4143-99AB-014899C5FED1Q36620622-55B3DD33-961A-4AE3-BD84-36DDD23B0503Q36802726-251CB186-6059-48EF-AD6D-1C42509DBE35Q37267195-D64BE8FE-E876-4CC9-9107-ABA2CE1983B9Q37513498-BBFB83A9-D42B-4AAE-8072-E1CF34E3E3D5Q40329744-9198C1C1-0BAF-4B9B-B1D0-91759691A52EQ42589251-E648F18C-053D-4FEC-9465-F9EF85538735
P2860
Development of subtype-specific and heterosubtypic antibodies to the influenza A virus hemagglutinin after primary infection in children
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of subtype-specifi ...... primary infection in children
@en
Development of subtype-specifi ...... primary infection in children.
@nl
type
label
Development of subtype-specifi ...... primary infection in children
@en
Development of subtype-specifi ...... primary infection in children.
@nl
prefLabel
Development of subtype-specifi ...... primary infection in children
@en
Development of subtype-specifi ...... primary infection in children.
@nl
P2093
P2860
P1476
Development of subtype-specifi ...... primary infection in children
@en
P2093
Burlington DB
van Wyke KL
P2860
P304
P407
P577
1985-05-01T00:00:00Z